人工血管:医療機器パイプライン分析2017

◆英語タイトル:Vascular Grafts - Medical Devices Pipeline Assessment, 2017
◆商品コード:GDME0411EPD
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年8月4日
◆ページ数:86
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Vascular Grafts – Medical Devices Pipeline Assessment, 2017
Summary

GlobalData’s Medical Devices sector report, “Vascular Grafts – Medical Devices Pipeline Assessment, 2017″ provides an overview of Vascular Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vascular Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Vascular Grafts under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Vascular Grafts and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Vascular Grafts under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Vascular Grafts Overview 7
3 Products under Development 8
3.1 Vascular Grafts – Pipeline Products by Stage of Development 8
3.2 Vascular Grafts – Pipeline Products by Segment 9
3.3 Vascular Grafts – Pipeline Products by Territory 10
3.4 Vascular Grafts – Pipeline Products by Regulatory Path 11
3.5 Vascular Grafts – Pipeline Products by Estimated Approval Date 12
3.6 Vascular Grafts – Ongoing Clinical Trials 13
4 Vascular Grafts – Pipeline Products under Development by Companies 14
4.1 Vascular Grafts Companies – Pipeline Products by Stage of Development 14
4.2 Vascular Grafts – Pipeline Products by Stage of Development 16
5 Vascular Grafts Companies and Product Overview 17
5.1 3S BioMedical, Inc. Company Overview 17
5.1.1 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Ariste Medical LLC Company Overview 19
5.2.1 Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 C. R. Bard Inc Company Overview 20
5.3.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Cardiojustable LLC (Inactive) Company Overview 24
5.4.1 Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
5.5 Colorado Therapeutics, LLC Company Overview 25
5.5.1 Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.6 CryoLife Inc Company Overview 26
5.6.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 DSM Biomedical BV Company Overview 27
5.7.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
5.8 Eqalix Inc Company Overview 28
5.8.1 Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.9 FIT Biotech Oy Company Overview 30
5.9.1 FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
5.10 Gel-Del Technologies, Inc. Company Overview 32
5.10.1 Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Graftworx, LLC Company Overview 33
5.11.1 Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Healionics Corporation Company Overview 34
5.12.1 Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Humacyte Inc Company Overview 35
5.13.1 Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Innovia LLC Company Overview 39
5.14.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.15 Northwestern University Company Overview 40
5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 NuVascular Technologies Inc Company Overview 41
5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 PetVivo Holdings Inc Company Overview 42
5.17.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 RegenaGraft Company Overview 43
5.18.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 44
5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
5.20 SurgaColl Technologies Ltd Company Overview 45
5.20.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 Universidad de Los Andes Company Overview 46
5.21.1 Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
5.22 University of Louisville Company Overview 47
5.22.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
5.23 Vascutek Ltd Company Overview 48
5.23.1 Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
5.24 VesselTek BioMedical LLC Company Overview 49
5.24.1 VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
5.25 VESSL Therapeutics Ltd Company Overview 51
5.25.1 VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
5.26 Xeltis AG Company Overview 52
5.26.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52
6 Vascular Grafts- Recent Developments 53
6.1 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 53
6.2 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 53
6.3 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 55
6.4 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 56
6.5 Jul 07, 2017: MPSC New COO Glendy Wang on Board 57
6.6 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 57
6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 59
6.8 Apr 27, 2017: Fit Biotech: Appointments in Fit Biotech’s Management 60
6.9 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 61
6.10 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 61
6.11 Apr 23, 2017: Bard Announces First Quarter Results 62
6.12 Apr 03, 2017: Retrospective Study Confirms Bovine Carotid Artery Biologic Graft Outperforms Expanded Polytetrafluoroethylene for Hemodialysis Access 63
6.13 Mar 30, 2017: FIT Biotech: Appointment to FIT Biotech’s Management Team 63
6.14 Mar 30, 2017: MPSC Announces 2016 Annual Results 64
6.15 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 66
6.16 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 66
6.17 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 67
6.18 Jan 26, 2017: Bard Announces Fourth Quarter Results 68
6.19 Jan 16, 2017: SurgaColl Technologies: Board Announcement – Appointment of CEO 69
6.20 Dec 29, 2016: Humacyte Commences U.S. Phase II Arterial Bypass Clinical Trial 69
6.21 Nov 03, 2016: DSM Q3 2016 Results 70
6.22 Nov 01, 2016: Xeltis Announces Multidisciplinary Scientific Advisory Board of Global Leading Experts 72
6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 73
6.24 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 75
6.25 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 76
6.26 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 76
6.27 Oct 25, 2016: Bard Announces Third Quarter Results 77
6.28 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 77
6.29 Sep 16, 2016: Federal Circuit Court of Appeals upholds LifeNet Health’s $34.7 million patent victory 78
6.30 Sep 14, 2016: Fit Biotech Oy’s Half-year Financial Report January 1-June 30, 2016 78
6.31 Sep 06, 2016: CryoLife Appoints James McDermid as Chief Human Resources Officer 80
6.32 Aug 30, 2016: MPSC Announces 2016 Interim Results 80
7 Appendix 83
7.1 Methodology 83
7.2 About GlobalData 86
7.3 Contact Us 86
7.4 Disclaimer 86

1.1 List of Tables
Table 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Table 2: Vascular Grafts - Pipeline Products by Segment 9
Table 3: Vascular Grafts - Pipeline Products by Territory 10
Table 4: Vascular Grafts - Pipeline Products by Regulatory Path 11
Table 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 12
Table 6: Vascular Grafts - Ongoing Clinical Trials 13
Table 7: Vascular Grafts Companies - Pipeline Products by Stage of Development 14
Table 8: Vascular Grafts - Pipeline Products by Stage of Development 16
Table 9: 3S BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Status 17
Table 11: Resorpor AdvaMatrix Micro Small Vessel Graft - Product Description 17
Table 12: Resorpor AdvaMatrixrPro Vessel Graft - Product Status 18
Table 13: Resorpor AdvaMatrixrPro Vessel Graft - Product Description 18
Table 14: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 19
Table 15: Drug Eluting Vascular Graft - Product Status 19
Table 16: Drug Eluting Vascular Graft - Product Description 19
Table 17: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: Covera Vascular Covered Stent Graft - Product Status 20
Table 19: Covera Vascular Covered Stent Graft - Product Description 21
Table 20: Lifestream Stent Graft - Product Status 21
Table 21: Lifestream Stent Graft - Product Description 21
Table 22: C. R. Bard Inc - Ongoing Clinical Trials Overview 22
Table 23: Lifestream Stent Graft - A Prospective, Multi-center, Non-randomized, Single-arm Study of the Bard Lifestream Balloon Expandable Vascular Covered Stent in the Treatment of Iliac Artery Occlusive Disease: BOLSTER 23
Table 24: Cardiojustable LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
Table 25: Adjustable SPA Shunt - Product Status 24
Table 26: Adjustable SPA Shunt - Product Description 24
Table 27: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Xenograft Implant - Peripheral Vascular Disease - Product Status 25
Table 29: Xenograft Implant - Peripheral Vascular Disease - Product Description 25
Table 30: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Synergraft Xenograft Vascular Graft - Product Status 26
Table 32: Synergraft Xenograft Vascular Graft - Product Description 26
Table 33: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 27
Table 34: Small Diameter Vascular Graft - Product Status 27
Table 35: Small Diameter Vascular Graft - Product Description 27
Table 36: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 28
Table 37: CardioVessel - Product Status 28
Table 38: CardioVessel - Product Description 28
Table 39: LCL Graft - Product Status 29
Table 40: LCL Graft - Product Description 29
Table 41: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview 30
Table 42: GTU X-Graft - Product Status 30
Table 43: GTU X-Graft - Product Description 30
Table 44: GTU X2-Graft - Product Status 31
Table 45: GTU X2-Graft - Product Description 31
Table 46: Gel-Del Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 32
Table 47: VasoGraft - Product Status 32
Table 48: VasoGraft - Product Description 32
Table 49: Graftworx, LLC Pipeline Products & Ongoing Clinical Trials Overview 33
Table 50: Smart Graft - Product Status 33
Table 51: Smart Graft - Product Description 33
Table 52: Healionics Corporation Pipeline Products & Ongoing Clinical Trials Overview 34
Table 53: STARgraft - Vascular Reconstruction - Product Status 34
Table 54: STARgraft - Vascular Reconstruction - Product Description 34
Table 55: Humacyte Inc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 56: HAV Graft - Vascular Trauma - Product Status 35
Table 57: HAV Graft - Vascular Trauma - Product Description 35
Table 58: HUMACYL - Peripheral Artery Disease - Product Status 36
Table 59: HUMACYL - Peripheral Artery Disease - Product Description 36
Table 60: Humacyte Inc - Ongoing Clinical Trials Overview 37
Table 61: HUMACYL - Peripheral Artery Disease - A Phase 2 Study for the Evaluation of Safety and Efficacy of Humacytes Human Acellular Vessel for Use as a Vascular Bypass or Interposition Vessel in Patients with Limb-threatening Peripheral Arterial Trauma 38
Table 62: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 63: 4mm Vascular Graft - Product Status 39
Table 64: 4mm Vascular Graft - Product Description 39
Table 65: Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 40
Table 66: ePTFE Graft - Peripheral Arterial Disease - Product Status 40
Table 67: ePTFE Graft - Peripheral Arterial Disease - Product Description 40
Table 68: NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 69: BioFunc - APC Vascular Graft - Product Status 41
Table 70: BioFunc - APC Vascular Graft - Product Description 41
Table 71: PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 72: Peripheral Vascular Graft - Product Status 42
Table 73: Peripheral Vascular Graft - Product Description 42
Table 74: RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 43
Table 75: RegenaVasc - Product Status 43
Table 76: RegenaVasc - Product Description 43
Table 77: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 44
Table 78: Enhanced Vascular Graft - Product Status 44
Table 79: Enhanced Vascular Graft - Product Description 44
Table 80: SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 45
Table 81: CardioColl - Product Status 45
Table 82: CardioColl - Product Description 45
Table 83: Universidad de Los Andes Pipeline Products & Ongoing Clinical Trials Overview 46
Table 84: SiSgraft - Product Status 46
Table 85: SiSgraft - Product Description 46
Table 86: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 47
Table 87: Vascular Graft System - Product Status 47
Table 88: Vascular Graft System - Product Description 47
Table 89: Vascutek Ltd Pipeline Products & Ongoing Clinical Trials Overview 48
Table 90: Triplex Advanced Vascular Graft - Product Status 48
Table 91: Triplex Advanced Vascular Graft - Product Description 48
Table 92: VesselTek BioMedical LLC Pipeline Products & Ongoing Clinical Trials Overview 49
Table 93: VTek Graft - Product Status 49
Table 94: VTek Graft - Product Description 49
Table 95: VTek-RA Wrap - Product Status 50
Table 96: VTek-RA Wrap - Product Description 50
Table 97: VESSL Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 98: MultiGeneGraft - Product Status 51
Table 99: MultiGeneGraft - Product Description 51
Table 100: Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 52
Table 101: Endogenous Tissue Growth Implant - Product Status 52
Table 102: Endogenous Tissue Growth Implant - Product Description 52
Table 103: Glossary 85

1.2 List of Figures
Figure 1: Vascular Grafts - Pipeline Products by Stage of Development 8
Figure 2: Vascular Grafts - Pipeline Products by Segment 9
Figure 3: Vascular Grafts - Pipeline Products by Territory 10
Figure 4: Vascular Grafts - Pipeline Products by Regulatory Path 11
Figure 5: Vascular Grafts - Pipeline Products by Estimated Approval Date 12
Figure 6: Vascular Grafts - Ongoing Clinical Trials 13

【掲載企業】

3S BioMedical, Inc.
Ariste Medical LLC
C. R. Bard Inc
Cardiojustable LLC
Colorado Therapeutics, LLC
CryoLife Inc
DSM Biomedical BV
Eqalix Inc
FIT Biotech Oy
Gel-Del Technologies, Inc.
Graftworx, LLC
Healionics Corporation
Humacyte Inc
Innovia LLC
Northwestern University
NuVascular Technologies Inc
PetVivo Holdings Inc
RegenaGraft
Sree Chitra Tirunal Institute for Medical Sciences & Technology
SurgaColl Technologies Ltd
Universidad de Los Andes
University of Louisville
Vascutek Ltd
VesselTek BioMedical LLC
VESSL Therapeutics Ltd
Xeltis AG

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 人工血管:医療機器パイプライン分析2017(Vascular Grafts - Medical Devices Pipeline Assessment, 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆